Manching Ku

Principal Investigator

Center for Pediatrics & Adolescent Medicine
Clinic for Pediatric Hematology & Oncology

Mathildenstr. 1
79106 Freiburg i. Brsg.

Current position

Group Leader, Clinic for Pediatric Hematology & Oncology, Center for Pediatrics & Adolescent Medicine, Medical Center – University of Freiburg

Academic training

1996 – 1999 Bachelors of Science, Biochemistry, University of Massachusetts, Boston, USA

Scientific qualifications

2000 – 2006 Doctor of Philosophy, Department of Biochemistry,
Tufts University, Boston, USA

Postgraduate Positions

since 2017 Group Leader, Clinic for Pediatric Hematology & Oncology, Center for Pediatrics & Adolescent Medicine,
Medical Center - University of Freiburg
2013 – 2017 Director, Next-generation Sequencing Core, Salk Institute for Biological Studies, La Jolla, USA
2012 Instructor, La Jolla Institute of Allergy and Immunology, La Jolla, USA
2006 – 2012 Croucher Postdoctorate, Broad Institute of Harvard and MIT, Massachusetts General Hospital, Harvard Medical School, Cambridge, USA

link to all publications from M. Ku: Pubmed

Publications based on CRC1160 funding

Phillips N, Ke E, Nham A, Seidl M, Freeman B, Abadejos JR, Xiao C, Nemazee D, Ku M, Kirak O. 2020. Prediabetes Induced by a Single Autoimmune B Cell Clone. Front Immunol. 2020 11:1073. doi: 10.3389/fimmu.2020.01073. eCollection 2020.

Marschner, D., M. Falk, N. R. Javorniczky, K. Hanke-Muller, J. Rawluk, Schmitt-Graeff, F. Simonetta, E. Haring, S. Dicks, M. Ku, S. Duquesne, K. Aumann, D. Rafei-Shamsabadi, F. Meiss, P. Marschner, M. Boerries, R. S. Negrin, J. Duyster, R. Zeiser, and N. Kohler. 2020. MicroRNA-146a regulates immune-related adverse events caused by immune checkpoint inhibitors. JCI insight 5. pii: 132334. doi: 10.1172/jci.insight.132334.